作者
Tomoyuki Fujita,Toshiyuki Yoshizato,Hiroshi Miyata,Takuya Shimomura,Takeshi Kuramoto,Hitoshi Obara,Hiroshi Ide,Koga Fumitoshi,Kayoko Kojima,Mari Nomiyama,Misato Fukagawa,Yumi Nagata,Atsushi Tanaka,Heimei Yuki,Takafumi Utsunomiya,Hidehiko Matsubayashi,Chikahiro Oka,Katsuya Yano,Masahide Shiotani,Masaru Fukuda,Hiroshi Hirai,Tatsuyuki Kakuma,Kimio Ushijima
摘要
Abstract
Objective
Assisted reproductive technology (ART), especially frozen–thawed embryo transfer (FET) in a hormone replacement cycle (HRC), is a risk factor for placenta accreta spectrum (PAS). This study aimed to clarify the risk factors for PAS related to the maternal background and ART techniques in pregnancies achieved after FET in an HRC. Study Design
We performed a case–control study in two tertiary perinatal centres in Japan. Among 14,028 patients who delivered at ≥24 weeks of gestation or were transferred after delivery to two tertiary perinatal centres between 2010 and 2021, 972 conceived with ART and 13,056 conceived without ART. PAS was diagnosed on the basis of the FIGO classification for the clinical diagnosis of PAS or retained products of conception after delivery at ≥24 weeks of gestation. We excluded women with fresh embryo transfer, FET with a spontaneous ovulatory cycle, a donor oocyte cycle, and missing details of the ART treatment. Finally, among women who conceived after FET in an HRC, 62 with PAS and 340 without PAS were included in this study. Multivariate logistic regression models were used for case–control comparisons, with adjustment for maternal age at delivery, parity, endometriosis or adenomyosis, the number of previous uterine surgeries of caesarean section, myomectomy, endometrial polypectomy or endometrial curettage, placenta previa, the stage of transferred embryos, and endometrial thickness at the initiation of progestin administration. Results
PAS was associated with ≥2 previous uterine surgeries (adjusted odds ratio, 3.57; 95% confidence interval, 1.60–7.97) and the stage of embryo transfer (blastocysts: adjusted odds ratio, 2.89; 95% confidence interval, 1.15–7.26). In patients with <2 previous uterine surgeries, PAS was associated with an endometrial thickness of <7.0 mm (adjusted odds ratio, 5.18; 95% confidence interval, 1.10–24.44). Conclusion
Multiple uterine surgeries and the transfer of blastocysts are risk factors for PAS in pregnancies conceived after FET in an HRC. In women with <2 previous uterine surgeries, a thin endometrium before FET is also a risk factor for PAS in these pregnancies.